Program in Health Economics and Outcomes Methodology (PHEnOM) Seminar
Weekly, Wednesdays 3:00- 4:30 pm, H371.
Click here for additional information and schedule
The CHOICE Institute Graduate Seminar (HEOR 597)
Wednesdays 12:30- 1:20pm, Health Sciences Education Building (HSEB) Room 245
To present in or attend the CHOICE seminar series, contact Dr. Jing Li jli0321@uw.edu.
Subscribe to the CHOICE Seminar email listserv.
Spring 2025 Seminar Schedule
| Date | Speaker | Topic |
| Apr 2 | No seminar–WPEC | |
| Apr 9 | Felipe Montano-Campos
CHOICE Institute, University of Washington |
Risk Perception and Preventive Behavior: Evidence of Risk Compensation Behaviors During the COVID-19 Pandemic |
|
Apr 16 |
Zizi Elsisi
CHOICE Institute, University of Washington |
Comparative Evaluation of Subscription-based Payment Model for Hepatitis C in Medicaid Managed Care |
|
Apr 23 |
Ron Dickerson
CHOICE Institute, University of Washington |
Missing Data and Spatial Dependence: Leveraging INLA and SPDE for Health Economics |
| Emma Cousin
CHOICE Institute, University of Washington |
Selecting and Negotiating Medicare Part B Drugs for IPAY 2028 |
|
| Apr 30 | Emily Callen
CHOICE Institute, University of Washington |
Evaluating the Effectiveness of State HIV Pre-exposure Prophylaxis Drug Assistance Programs
|
| Ben Nwogu
CHOICE Institute, University of Washington |
Comparative Effectiveness of Multiple Treatments in Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): A Proposed Study Using Claims Data |
|
|
May 7 |
Tori Dayer
CHOICE Institute, University of Washington |
The US Biosimilars Market: Economic Factors and Patient Out-of-Pocket Costs |
| May 14 | No seminar–ISPOR | |
|
May 21 |
Karris Jeon
CHOICE Institute, University of Washington |
Medicare Drug Price Negotiation: Projected Savings in 2026
|
| Julia Fox
CHOICE Institute, University of Washington |
Modeling Information Sharing and Referral Acceptance Dynamics Among People who Inject Drugs | |
| May 28
CHOICE MS Fellows Presentations I
|
Olivia Yip |
Healthcare Utilization and Cost Burden Associated with Depression among Patients with Alzheimer’s Disease |
| Rachel Kneitel | Healthcare Resource Utilization and Economic Burden in Patients with AML Treated with Post-Transplant Maintenance Therapy | |
|
Minseon Chung
|
Cost effectiveness and expected value of perfect information of delaying progression of Alzheimer’s Disease with novel monoclonal antibodies | |
|
Divya Jain |
Urban-Rural Differences in Healthcare Utilization and Expenditures among Multiple Sclerosis patients in the United States | |
|
Jun 4 CHOICE MS Fellows Presentations II |
Kathryn Perkins |
Impact of Cachexia on Costs and Resource Utilization in Patients with Pancreatic, Lung, or Colorectal Cancers |
|
Kevin Li |
Switch rates, healthcare resource utilization and costs of commercially insured US patients with atopic dermatitis switching from systemic first-line to second-line targeted therapies | |
|
Jean Lee |
Healthcare resource utilization and costs treated with SGLT2-inhibitors and MRA vs. SGLT2-inhibitors and ARNI in HFPEF patients in the United States | |
| Nissen Weisman | Healthcare Resource Utilization Attributable to Mantle Cell Lymphoma in the Third-Line Setting | |